R. Love, “By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer”, Arch Breast Cancer, pp. 8–13, Jan. 2021.